A new blood test based on 10 "biomarker" proteins will make it possible to test new treatments at an early stage of Alzheimer's progression.
Writing in the journal Alzheimer's & Dementia, researchers from King's College London describe how they investigated 26 proteins previously associated with Alzheimer's disease.
They analysed blood samples from 476 confirmed Alzheimer's patients, 220 individuals with "mild cognitive impairment" (MCI) who experienced occasional memory loss, and 450 healthy elderly people.
In the vast majority of cases, memory lapses do not lead to Alzheimer's. But the researchers identified 10 blood proteins that appeared in 87% of MCI patients diagnosed with the disease within a year.
More top news
Wet and windy weather spreading across northern and some western parts, with some heavy rain likely across Northern Ireland and Scotland.
Online video giant YouTube has been condemned for failing to take down extremist content including films praising Hitler and the Taliban.
It is much more plausible that Hammond rather than Johnson would end up resigning after May reveals more about the kind of Brexit she wants.